Display options
Cite
Lakhan SE, Kirchgessner A. Prescription stimulants in individuals with and without attention deficit hyperactivity disorder: misuse, cognitive impact, and adverse effects. Brain Behav. 2012;2(5):661-77doi: 10.1002/brb3.78.
Lakhan, S. E., & Kirchgessner, A. (2012). Prescription stimulants in individuals with and without attention deficit hyperactivity disorder: misuse, cognitive impact, and adverse effects. Brain and behavior, 2(5), 661-77. https://doi.org/10.1002/brb3.78
Lakhan, Shaheen E, and Kirchgessner, Annette. "Prescription stimulants in individuals with and without attention deficit hyperactivity disorder: misuse, cognitive impact, and adverse effects." Brain and behavior vol. 2,5 (2012): 661-77. doi: https://doi.org/10.1002/brb3.78
Lakhan SE, Kirchgessner A. Prescription stimulants in individuals with and without attention deficit hyperactivity disorder: misuse, cognitive impact, and adverse effects. Brain Behav. 2012 Sep;2(5):661-77. doi: 10.1002/brb3.78. Epub 2012 Jul 23. PMID: 23139911; PMCID: PMC3489818.
Copy Download .nbib Format: NLM
Share it on

Brain Behav. 2012 Sep;2(5):661-77. doi: 10.1002/brb3.78. Epub 2012 Jul 23.

Prescription stimulants in individuals with and without attention deficit hyperactivity disorder: misuse, cognitive impact, and adverse effects.

Brain and behavior

Shaheen E Lakhan, Annette Kirchgessner

Affiliations

  1. Global Neuroscience Initiative Foundation Los Angeles, California.

PMID: 23139911 PMCID: PMC3489818 DOI: 10.1002/brb3.78

Abstract

Prescription stimulants are often used to treat attention deficit hyperactivity disorder (ADHD). Drugs like methylphenidate (Ritalin, Concerta), dextroamphetamine (Dexedrine), and dextroamphetamine-amphetamine (Adderall) help people with ADHD feel more focused. However, misuse of stimulants by ADHD and nonaffected individuals has dramatically increased over recent years based on students' misconceptions or simple lack of knowledge of associated risks. In this review, we discuss recent advances in the use and increasing misuse of prescription stimulants among high school and college students and athletes. Given the widespread belief that stimulants enhance performance, there are in fact only a few studies reporting the cognitive enhancing effects of stimulants in ADHD and nonaffected individuals. Student athletes should be apprised of the very serious consequences that can emerge when stimulants are used to improve sports performance. Moreover, misuse of stimulants is associated with dangers including psychosis, myocardial infarction, cardiomyopathy, and even sudden death. As ADHD medications are prescribed for long-term treatment, there is a need for long-term safety studies and education on the health risks associated with misuse is imperative.

Keywords: Amphetamine; athletes; attention deficit hyperactivity disorder; cognition; methylphenidate; misuse; performance; students

References

  1. J Neurosci. 2000 Mar 15;20(6):RC65 - PubMed
  2. Electroencephalogr Clin Neurophysiol. 1995 Nov;95(5):359-71 - PubMed
  3. J Am Board Fam Med. 2009 Mar-Apr;22(2):197-201 - PubMed
  4. Pediatrics. 2007 Feb;119 Suppl 1:S99-106 - PubMed
  5. Psychophysiology. 1983 Jul;20(4):359-70 - PubMed
  6. Proc Natl Acad Sci U S A. 2003 May 13;100(10):6186-91 - PubMed
  7. Psychopharmacology (Berl). 1999 Oct;146(4):482-91 - PubMed
  8. Psychopharmacology (Berl). 1993;111(1):1-16 - PubMed
  9. J Neurosci. 2012 Feb 22;32(8):2619-27 - PubMed
  10. Neurosci Biobehav Rev. 2010 Jul;34(8):1256-66 - PubMed
  11. Psychophysiology. 1984 Nov;21(6):609-21 - PubMed
  12. Biol Psychiatry. 2004 Oct 15;56(8):597-606 - PubMed
  13. Exp Clin Psychopharmacol. 2007 Apr;15(2):123-33 - PubMed
  14. Curr Sports Med Rep. 2011 Jan-Feb;10(1):32-6 - PubMed
  15. J Atten Disord. 2006 Aug;10(1):9-19 - PubMed
  16. Neuroimage. 2005 Apr 15;25(3):868-76 - PubMed
  17. N Engl J Med. 2011 Nov 17;365(20):1896-904 - PubMed
  18. Science. 1978 Feb 3;199(4328):560-3 - PubMed
  19. J Clin Psychiatry. 2010 Jun;71(6):754-63 - PubMed
  20. J Dent Educ. 2011 Mar;75(3):365-76 - PubMed
  21. J Neurol Sci. 2006 Oct 25;248(1-2):42-7 - PubMed
  22. J Neurosci. 1996 Aug 1;16(15):4816-22 - PubMed
  23. Prim Care. 2006 Jun;33(2):xiii-xviii - PubMed
  24. Mol Psychiatry. 2004 May;9(5):500-9 - PubMed
  25. Braz J Psychiatry. 2003 Sep;25(3):127-8 - PubMed
  26. Clin J Sport Med. 2011 Sep;21(5):392-401 - PubMed
  27. Psychopharmacology (Berl). 2006 Aug;187(2):154-69 - PubMed
  28. Behav Neurosci. 2000 Aug;114(4):830-7 - PubMed
  29. J Clin Psychiatry. 2008 Jul;69(7):1150-6 - PubMed
  30. J Neurosci. 2012 Jan 18;32(3):841-9 - PubMed
  31. Hum Psychopharmacol. 2007 Jul;22(5):279-87 - PubMed
  32. Psychophysiology. 1998 Jan;35(1):73-85 - PubMed
  33. J Am Board Fam Pract. 2002 Nov-Dec;15(6):498-500 - PubMed
  34. Am J Psychiatry. 2007 Jun;164(6):942-8 - PubMed
  35. Biol Psychiatry. 1998 May 15;43(10):723-9 - PubMed
  36. Psychopharmacology (Berl). 1994 Jun;115(1-2):46-52 - PubMed
  37. JAMA. 1985 Aug 16;254(7):946-7 - PubMed
  38. World Psychiatry. 2003 Jun;2(2):104-13 - PubMed
  39. Arch Gen Psychiatry. 2007 Aug;64(8):932-40 - PubMed
  40. Science. 1967 Feb 17;155(3764):849-51 - PubMed
  41. Drug Alcohol Depend. 2005 Feb 14;77(2):151-9 - PubMed
  42. J Invasive Cardiol. 2007 Apr;19(4):E89-92 - PubMed
  43. N Engl J Med. 1999 Mar 11;340(10):780-8 - PubMed
  44. J Am Acad Child Adolesc Psychiatry. 2009 May;48(5):484-500 - PubMed
  45. Vital Health Stat 10. 2007 Sep;(234):1-79 - PubMed
  46. Psychopharmacology (Berl). 1997 May;131(2):196-206 - PubMed
  47. J Neurosci. 2009 Apr 15;29(15):4690-6 - PubMed
  48. Psychopharmacology (Berl). 1997 Feb;129(3):271-6 - PubMed
  49. Curr Drug Abuse Rev. 2009 May;2(2):157-76 - PubMed
  50. MMWR Morb Mortal Wkly Rep. 2005 Sep 2;54(34):842-7 - PubMed
  51. Psychopharmacologia. 1962 Mar 12;3:23-34 - PubMed
  52. Psychophysiology. 1988 May;25(3):292-304 - PubMed
  53. J Clin Psychiatry. 2008 Aug;69(8):1217-22 - PubMed
  54. J Atten Disord. 2009 Sep;13(2):144-53 - PubMed
  55. J Child Adolesc Psychopharmacol. 2005 Oct;15(5):799-809 - PubMed
  56. Pediatr Cardiol. 2012 Apr;33(4):679 - PubMed
  57. J Atten Disord. 2008 Jan;11(4):459-69 - PubMed
  58. Clin Pediatr (Phila). 1978 Jan;17(1):85-92 - PubMed
  59. Pediatr Cardiol. 2012 Jan;33(1):155-7 - PubMed
  60. Pharmacol Biochem Behav. 1987 Oct;28(2):213-7 - PubMed
  61. J Am Acad Child Adolesc Psychiatry. 2000 Nov;39(11):1424-31 - PubMed
  62. Psychopharmacology (Berl). 2009 Jan;202(1-3):541-7 - PubMed
  63. Acad Psychiatry. 2010 May-Jun;34(3):220-3 - PubMed
  64. N Engl J Med. 2005 Sep 15;353(11):1089-91 - PubMed
  65. Arch Gen Psychiatry. 1999 Dec;56(12):1073-86 - PubMed
  66. Neuropsychopharmacology. 2004 Sep;29(9):1704-14 - PubMed
  67. Exp Clin Psychopharmacol. 2011 Dec;19(6):433-44 - PubMed
  68. J Consult Clin Psychol. 1990 Feb;58(1):130-133 - PubMed
  69. J Neurochem. 1997 May;68(5):2032-7 - PubMed
  70. Psychosomatics. 1991 Spring;32(2):203-8 - PubMed
  71. J R Soc Med. 1992 Jul;85(7):399-402 - PubMed
  72. Dev Psychobiol. 2005 Sep;47(2):145-57 - PubMed
  73. Am J Psychol. 1969 Sep;82(3):307-19 - PubMed
  74. Pediatrics. 2005 Jun;115(6):e749-57 - PubMed
  75. Psychopharmacology (Berl). 2007 Jun;192(3):425-40 - PubMed
  76. J Physician Assist Educ. 2011;22(4):15-22 - PubMed
  77. Psychopharmacology (Berl). 1995 May;119(2):155-62 - PubMed
  78. Am J Psychiatry. 2012 Feb;169(2):178-85 - PubMed
  79. Psychol Med. 2006 Feb;36(2):167-79 - PubMed
  80. Exp Clin Psychopharmacol. 1997 May;5(2):130-6 - PubMed
  81. J Atten Disord. 2008 Sep;12(2):115-25 - PubMed
  82. J Am Pharm Assoc (2003). 2009 Jul-Aug;49(4):519-28 - PubMed
  83. Can J Psychiatry. 2005 Jul;50(8):457-61 - PubMed
  84. Am J Psychiatry. 2012 Feb;169(2):160-6 - PubMed
  85. J Psychol. 1998 Mar;132(2):227-37 - PubMed
  86. MMWR Morb Mortal Wkly Rep. 2010 Nov 12;59(44):1439-43 - PubMed
  87. J Am Acad Child Adolesc Psychiatry. 2008 Jan;47(1):21-31 - PubMed
  88. J Nerv Ment Dis. 2012 Jan;200(1):69-75 - PubMed
  89. Curr Clin Pharmacol. 2011 Feb;6(1):1-11 - PubMed
  90. J Integr Neurosci. 2005 Mar;4(1):123-44 - PubMed
  91. Annu Rev Med. 2002;53:113-31 - PubMed
  92. J Investig Med. 2004 Apr;52(3):192-201 - PubMed
  93. J Am Coll Health. 2005 May-Jun;53(6):253-62 - PubMed
  94. Aviat Space Environ Med. 1988 May;59(5):407-10 - PubMed
  95. Am J Psychiatry. 2012 Feb;169(2):167-77 - PubMed
  96. Psychopharmacol Bull. 1995;31(2):357-62 - PubMed
  97. Pharmacotherapy. 2009 Jun;29(6):656-79 - PubMed
  98. JAMA. 2004 Aug 4;292(5):619-23 - PubMed
  99. J Psychopharmacol. 2007 Sep;21(7):673-83 - PubMed
  100. J Psychol. 1965 May;60:71-9 - PubMed
  101. Am J Health Syst Pharm. 2005 Jul 15;62(14):1494-7 - PubMed
  102. Neuropsychopharmacology. 2002 Nov;27(5):813-25 - PubMed
  103. Psychiatr Serv. 2000 Oct;51(10):1299-304 - PubMed
  104. Schizophr Res. 2005 Sep 1;77(1):43-58 - PubMed
  105. J Dev Behav Pediatr. 1998 Jun;19(3):187-92 - PubMed
  106. J Am Acad Child Adolesc Psychiatry. 2007 Aug;46(8):989-1002 - PubMed
  107. Neuroimage. 2000 Sep;12(3):268-75 - PubMed
  108. Neuropsychobiology. 1997;36(1):42-8 - PubMed
  109. JAMA. 2011 Dec 28;306(24):2673-83 - PubMed
  110. Psychopharmacol Bull. 1984 Winter;20(1):3-9 - PubMed
  111. PLoS One. 2011;6(11):e28416 - PubMed
  112. J Clin Psychiatry. 2003;64 Suppl 11:14-8 - PubMed
  113. Aviat Space Environ Med. 1990 Jul;61(7):615-21 - PubMed
  114. Arch Gen Psychiatry. 1995 Jun;52(6):456-63 - PubMed
  115. Neuron. 2002 Oct 10;36(2):229-40 - PubMed
  116. Psychol Med. 1997 Mar;27(2):291-300 - PubMed
  117. Expert Opin Pharmacother. 2001 Apr;2(4):573-86 - PubMed
  118. Psychol Bull. 2011 Sep;137(5):717-41 - PubMed
  119. Arch Gen Psychiatry. 2005 Oct;62(10):1142-7 - PubMed
  120. J Am Coll Health. 2008 May-Jun;56(6):601-6 - PubMed
  121. Subst Use Misuse. 2004 Jun;39(7):1095-116 - PubMed
  122. Addict Behav. 2005 Aug;30(7):1342-50 - PubMed
  123. Catheter Cardiovasc Interv. 2011 Nov 15;78(6):910-3 - PubMed
  124. J Neurosci. 2008 Jun 4;28(23):5976-82 - PubMed
  125. Am J Psychiatry. 2006 Apr;163(4):716-23 - PubMed
  126. Neurosci Lett. 1993 Oct 14;161(1):9-12 - PubMed
  127. Addiction. 2005 Jan;100(1):96-106 - PubMed

Publication Types